Search - tctmd.com

Displaying 81 - 100 of 169

Sort: Relevancy | Date

Presentation TCT 2020

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

Presenter: Joshua Aymond

October 14, 2020

Presentation TCT 2020

TCT 573: The First Case of Impella RP Use in Acute Right Ventricular Failure From Air Embolism

Presenter: Yaser Khalid

October 14, 2020

News Daily News

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Caitlin E. Cox

August 18, 2020

News Daily News

Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest

Shelley Wood

August 05, 2020

News Features

Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

Caitlin E. Cox

June 02, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

Todd Neale

April 29, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Daily News

Impella Redux: JAMA Publication Post-AHA Renews Push for More Data

Caitlin E. Cox

February 14, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

Caitlin E. Cox

November 17, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

Advertisement

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

TCT 573: The First Case of Impella RP Use in Acute Right Ventricular Failure From Air Embolism

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Simple MIRACLE2 Score Could Help Triage Out-of-Hospital Cardiac Arrest

Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

TCTMD’s Top 10 Most Popular Stories for February 2020

Impella Redux: JAMA Publication Post-AHA Renews Push for More Data

TCTMD’s Top 10 Most Popular Stories for November 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content